SCHEMBL4936550

SCHEMBL4936550

ClCCN(CCCl)Cc1cccc(Nc2c3ccccc3nc3ccccc23)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 2/20 0.64
TOP2B Q02880 2/20 0.64
KMT2A Q03164 3/20 0.53
POLB P06746 2/20 0.53
RAD52 P43351 2/20 0.53
MEN1 O00255 1/20 0.53
GFER P55789 1/20 0.53
KDM1A O60341 10/20 0.53
L3MBTL1 Q9Y468 1/20 0.50
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
GLA P06280 1/20 0.48
GAA P10253 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HDAC4 P56524 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
ACP1 P24666 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933340 0.85 KDM1A (0.57) KMT2APOLBRAD52MEN1GFER
SCHEMBL4934135 0.80 KDM1A (0.48) TOP2ATOP2BKMT2APOLBRAD52
SCHEMBL3985866 0.78 TOP2A (1.00) TOP2ATOP2BKMT2APOLBRAD52
SCHEMBL4936777 0.78 KDM1A (0.46) TOP2ATOP2BKMT2APOLBRAD52
SCHEMBL9603246 0.76 TOP2A (0.79) TOP2ATOP2BKMT2APOLBRAD52
SCHEMBL4941610 0.76 PARP1 (0.42) TOP2ATOP2BRAD52KDM1AL3MBTL1
SCHEMBL4910290 0.73 TOP2A (0.55) TOP2ATOP2BKMT2APOLBRAD52
SCHEMBL17154456 0.73 KDM1A (0.70) KMT2APOLBRAD52GFERKDM1A
SCHEMBL4941215 0.72 KMT2A (0.61) KMT2APOLBRAD52MEN1GFER
SCHEMBL4933388 0.72 KDM1A (0.49) TOP2ATOP2BKMT2APOLBRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176889-A1 9-anilinoacridine alkylating agents ACADEMIA SINICA (TW) 2008-07-24 US disclosed
US-20080176889-A1 9-anilinoacridine alkylating agents ACADEMIA SINICA (TW) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176889-A1 9-anilinoacridine alkylating agents BCL9, MCL1, BCL9L TOP2A 5/4885TOP2B 7/4885KMT2A 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.